Levrett Share Discussion Threads

[maytrees] 23/9/2016 16:02

Greetings thirdmanharry

You may be right of course but in part that may depend on how far towards testing and completion Nuformix have gone with their products before the tie up with LVRT.

Having sold c. half of my LVRT holding upon the share price taking off b4 suspension, waiting and seeing what the outcome of any RTO will be, is not going to be expensive, even if your point is correct.

Yr point is so obvious however that I cannot see any small co like LVRT agreeing to an RTO unless there was more if not in sight, at least pending v. soon.

[thirdmanharry] 23/9/2016 15:31

The last accounts filed by Nuformix make sorry reading: tangible fixed assets of only £2,513 and insufficient cash to pay creditors falling due within 1 year of £342,996; with a deficit on the P&L of over £600,000 the company has a negative net worth. What a dog! Clearly, as LVRT only has a small amount of cash itself (about £500,000), a massive placing will be required for the merged company as businesses like Nuformix are cash guzzlers. This is a very small acquisition which will require massive funding and a great deal of luck to make it a sector dominated by much better resourced companies. It's likely to be the usual 'its better to travel than to arrive' play (i.e. vintage Regan).

[jimduggen] 21/9/2016 22:23

The lower the better. Probably be 10p imo. 4p would be lovely but i can not see that.

[maytrees] 21/9/2016 15:11

Many tx jimduggan

Upon the initial flotation of LVRT on AIM its share price was 2p so assuming the rto goes ahead, a bid share price of say 4p upon the suspension being lifted, would not be too bad especially as it was as low as 1.75 not that long ago.

[jimduggen] 21/9/2016 14:19

There was a couple of levrett rns out today. On my hl account.

[maytrees] 21/9/2016 08:31

Greetings jimduggen

I am no expert. My guess is though that the directors of Nuformix will wish to see considerable new capital in the combined co.

Forming a new LSE or even AIM co is very expensive prohibitively so for many small companies. Using an existing clean shell co like LVRT may be a cheaper and speedier way in.

Obviously LVRT's owner/shareholders even existing PI shareholders, will need to benefit but I imagine the key is to raise substantial funds for Nuformix in respect of which both cos will need advice as to the numbers of new shares to be issued bearing in mind the need to secure a fair opening price on the AIM market.

For existing LVRT shareholders the combined share price needs imho, to be at the equivalent of 4p+ as that was the share price before suspension.

The "equivalent" share price will of course depend upon the number of new shares to be issued including the number of new shares exchanged for each LVRT share.

Of course the sum may be well over 4p.

Alternatively if the new co is regarded as unattractive or is never formed, rather less than 4p!

[jimduggen] 20/9/2016 19:28

Thankyou :)
How do you forsee the restructuring of levrett the "new co" being formed?

How many millions of shares in issue could the new entity come back with?

If you hold 400k shares will you still have that amount in the new company?

[maytrees] 20/9/2016 13:17

Greetings jimduggan

O/T: Blogging started really as an experiment a few years ago but became more interesting so I kept it going.

Please feel free to add comments - and tx to yr mum!

[runwaypaul] 19/9/2016 21:07

that's what they all say.atb

[jimduggen] 19/9/2016 21:06

Will be 3 months tops

[jimduggen] 19/9/2016 21:04

Thanks keya

Will keep in mind

[runwaypaul] 19/9/2016 21:03

see you back in 10 months then.

[jimduggen] 19/9/2016 20:52

Great minds think alike ;)

[jimduggen] 19/9/2016 20:45

Maytrees musings lol. My mum sent me your blog.
Interesting :)

[maytrees] 17/9/2016 09:42

Good morning Liamnich04

Many thanks.

As shell company investment is a novelty for me at least, I sold about 50% of my comparatively large stake to take the large share price gains that were made yesterday b4 suspension.

The point of my retaining the rest, is to establish whether one is best advised to sell or retain on an RTO being announced, bearing in mind that surely the RTO will involve the issue of many more shares.

Obviously much depends on the quality of the other co in the RTO but from your post this seems very positive in LVRT's case.

[liamnich04] 16/9/2016 19:45

Could be huge

Nuformix is focused on pharmaceutical cocrystallisation. Our technology allows the creation of new intellectual property and competitive advantages for existing drugs.

By leveraging these advantages and the team’s significant experience Nuformix has created new therapies targeting unmet medical need in both reprofiled and existing indications.

Nuformix is validating its lead programmes in parallel to ongoing cocrystal discovery and development activities.

3 patents

Nuformix CEO Dr Dan Gooding commented “We are again delighted to see a third Nuformix patent application granted. The news further validates Nuformix’s strategy of securing broad and robust IP coverage for vastly superior forms of known drugs. Our relationship with J.A.Lindeman LLC continues to pay great dividends. This is also excellent news for Dynasty Biotechnology, who are leading the development of NX006 in China before returning to the US for product registration.”

NX006 is a leading treatment in pain management. Under development by Dynasty Biotechnology NX006 will yield a first-in-China product with a unique dosage and PK profile, resulting in a patient-centred therapy that is otherwise unobtainable via any approach that utilises the inferior parent form.

Dr Dan Gooding, CEO
Dan brings over 12 years experience in commercialisation and business development within the pharmaceutical industry. Dr Gooding began his career in commercial roles with excipients companies such as FMC and Dow Corning. At Accelrys Dan was responsible for sales across Europe driving new business within nanotechnology, drug delivery and formulation sectors. Dan has also led successful licensing deals within the pharmaceutical industry with companies such as Johnson & Johnson and AstraZeneca. Dan is a cofounder of Nuformix.

[maytrees] 16/9/2016 13:35

RNS just out:

Levrett plc ("Levrett" or the "Company")

Possible Acquisition and Suspension of Trading

The Directors of Levrett are pleased to inform shareholders that the Company has signed a non-binding letter of intent to acquire the entire issued share capital of Nuformix Limited, a UK incorporated company operating in the cocrystal technology sector, for new shares in the Company (the "Acquisition").

The Acquisition is subject, inter alia, to the completion of due diligence, documentation and compliance with all regulatory requirements, including the Listing and Prospectus Rules and, as required, the Takeover Code.

The Company intends to convene a General Meeting as soon as practicable in order to seek the shareholder approvals necessary to pursue this opportunity. It should also be noted that if the Acquisition proceeds, further shareholder consent may also be required including to deal with any applicable requirements of the Takeover Code.

Suspension and Application for Listing

The Acquisition, if it proceeds, will constitute a Reverse Takeover under the Listing Rules since, inter alia, in substance it will result in a fundamental change in the business of the issuer.

As the Acquisition will constitute a Reverse Takeover under the Listing Rules, trading in the Company's ordinary shares have been suspended (pursuant to Listing Rule 5.3.1) with immediate effect pending the publication of a prospectus and the application for the enlarged Company to have its ordinary shares admitted to the Official List and to trading on the main market for listed securities of the London Stock Exchange.

The Company is working on the preparation of a prospectus in relation to the Acquisition and will, in due course, be making application for the enlarged Company to have its ordinary shares admitted to the Official List and to trading on the main market for listed securities of the London Stock Exchange.

The Company will update shareholders as the matter progresses.

Enquiries:

Levrett Plc
Pascal Hughes, CEO

[phone]


Whitman Howard Limited
Niall Baird / Nick Lovering

[phone]

[maytrees] 16/9/2016 13:27

The suspension though apparent from L2 has not so far as I can see yet been formally announced- strange?

[maytrees] 16/9/2016 13:21

Share trades in LVRT are now suspended presumably pending an announcement.

[letmepass] 16/9/2016 12:33

Pgy looking good with results any day

[jimduggen] 16/9/2016 09:59

I would reccomend holding as only 95 million shares in issue